Emitido el 27 de abril de 2020
Thrombotic and Hemostatic Issues in Critical Care Units Managing COVID-19
Webinar sobre problemas trombóticos y hemostáticos en unidades de cuidados intensivos (UCI) gestionando COVID-19, organizado por la International Society on Thrombosis and Haemostasis (ISTH).
Jerrold H. Levy, MD, FAHA, FCCM
Co-Director, Cardiothoracic ICU @Duke University Hospital
Jerrold Levy is Professor of Anesthesiology, Associate Professor of Surgery, and Co-Director of the Cardiothoracic Surgical Intensive Care Unit at Duke University Medical Center, Durham, NC, USA. He obtained his medical degree from the University of Miami, FL, where he was an intern in medicine, and undertook his residency in the Department of Anesthesiology of the Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, where he also completed two fellowships in Cardiac Anesthesia and in the Respiratory Intensive Care Unit.
Nicole P. Juffermans, MD, PhD
Professor of Translational Intensive Care Medicine @Amsterdam University Medical Center
Prof. Dr. Nicole Juffermans is board certified in internal medicine and in Intensive Care Medicine since 2006. She is an intensive care physician and staff member at the Department of Intensive Care Medicine at the OLVG Hospital, a large teaching hospital in Amsterdam. She is PI of the Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.) of the Amsterdam University Medical Center. She is appointed professor of translational Intensive Care at the University of Amsterdam since 2016. In collaboration with international study groups in the field of trauma, transfusion and coagulation, she performs basic research and clinical trials on efficacy and alternatives of blood transfusion as well as on diagnostics of coagulation. She has published > 240 articles in peer-reviewed journals.
Jean M. Connors, MD
Medical Director, Anticoagulation Management Service @Brigham and Women’s Hospital and Dana-Farber Cancer Institute
Jean M Connors MD is a hematology attending at Brigham and Women’s Hospital and Dana Farber Cancer Institute, the Medical Director of the inpatient Hemostatic Antithrombotic Stewardship program and the outpatient Anticoagulation Management Services, and an associate professor of medicine at Harvard Medical School. She attended Johns Hopkins School of Medicine, did medical residency at Beth Israel Hospital Boston, and completed fellowship training in hematology-oncology at Brigham and Women’s Hospital and in transfusion medicine at the Harvard Joint Program in Transfusion Medicine. Dr. Connors has participated in numerous clinical trials for patients with venous thrombosis, is currently participating in the trials of reversal agents for the direct oral anticoagulants, and is the leading national level trials to study the use of DOAC in cancer associated venous thromboembolism.